Major depressive disorder is a complex mood disorder that affects millions of people. For some individuals, traditional antidepressant medications do not provide adequate relief from their symptoms. This has led medical researchers to explore new therapeutic avenues; one such development in the field of psychiatry is a nasal spray under the brand name Spravato. Understanding its function requires a clear picture of both the condition it treats and the specifics of the medication itself.
What Is Depression?
Depression is more than just feeling sad. It is a persistent medical condition that negatively affects how a person feels, thinks, and acts. Symptoms can vary in severity and may include a continuous low mood, loss of interest in activities once enjoyed, changes in appetite or weight, difficulty sleeping or sleeping too much, and feelings of worthlessness or guilt.
The underlying causes of depression are multifaceted and involve a combination of genetic, biological, environmental, and psychological factors. Standard oral antidepressants often work by adjusting the levels of chemicals in the brain. For many patients, these medications are effective. A segment of the population, though, experiences what is known as treatment-resistant depression, where they do not respond sufficiently to at least two different oral antidepressant trials.
What Is Spravato?
Spravato is the brand name for esketamine, a prescription medication delivered as a nasal spray. It can be used in conjunction with an oral antidepressant for adults with treatment-resistant depression. It represents a different mechanism of action compared to many conventional antidepressants.
Spravato works through a different pathway than most oral antidepressants. It targets the NMDA receptor. Spravato is thought to help restore synaptic connections in the brain cells of people with major depressive disorder. Due to its mechanism and potential side effects, Spravato is administered under the direct supervision of a healthcare provider in a certified medical office or clinic. Patients cannot take the medication home; this controlled setting allows for monitoring during and after treatment.
What Should You Expect?
The treatment journey with Spravato follows a structured protocol. Before beginning, a healthcare provider will conduct a thorough evaluation to determine if this treatment is appropriate for the patient’s specific condition and medical history. Patients may be instructed not to eat and not to drink liquids before their appointment.
During a treatment session, the patient will self-administer the Spravato nasal spray under the observation of a healthcare professional. After administration, patients are monitored in the clinic for at least two hours. Common side effects can include a sense of dissociation, dizziness, or fatigue. The medical staff observes the patient until they determine the patient is safe to leave. Patients should arrange for transportation home and should not drive or operate heavy machinery for the rest of the day because of potential drowsiness.
The dosing schedule typically begins with an induction phase, where treatment is administered twice a week for the first month. This is followed by a maintenance phase, where the frequency of treatments may be reduced based on the individual’s response and clinical judgment. Throughout the treatment course, patients continue to take their daily oral antidepressant as prescribed.
Confer With a Medical Specialist
Navigating treatment options for depression requires a collaborative partnership with a qualified healthcare professional. Spravato is a specialized treatment intended for specific situations and is not a first-line therapy. A medical specialist can perform a comprehensive assessment of your mental and physical health, ascertaining if you meet the criteria for treatment-resistant depression. They will review your history with other medications and therapies to build a complete clinical picture.
Leave a Reply